Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | GABBR2 | O75899 | 2/20 | 0.45 |
| ▸ | GABBR1 | Q9UBS5 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MPO | P05164 | 1/20 | 0.43 |
| ▸ | TPO | P07202 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2628023 | 0.85 | IDO1 (0.42) | TACR1HTTSMN1; SMN2MPOTPO | |
| SCHEMBL1879700 | 0.82 | TACR1 (0.59) | TACR1TSHRGABBR2GABBR1HTR2A | |
| Hydrochloric Acid SCHEMBL1874510 | 0.81 | TACR1 (0.57) | TACR1TSHRGABBR2GABBR1 | |
| SCHEMBL7964372 | 0.79 | TSHR (0.50) | TACR1TSHRHTTSMN1; SMN2MPO | |
| SCHEMBL3580534 | 0.79 | TSHR (0.50) | TACR1TSHRHTTSMN1; SMN2MPO | |
| SCHEMBL20207392 | 0.77 | TSHR (0.48) | TACR1TSHRHTTSMN1; SMN2MPO | |
| SCHEMBL20177696 | 0.77 | TSHR (0.48) | TACR1TSHRHTTSMN1; SMN2MPO | |
| SCHEMBL22870057 | 0.77 | CA1 (0.50) | TACR1TSHRHTTSMN1; SMN2IDO1 | |
| SCHEMBL2633195 | 0.77 | HTR2A (0.42) | TSHRGABBR2GABBR1HTR2ATAAR1 | |
| SCHEMBL28214514 | 0.76 | TSHR (0.40) | TACR1TSHRHTTSMN1; SMN2MPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8357809-B2 | Acyclic IKur inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-01-22 | — | — | US | disclosed |
| US-20120094983-A1 | ACYCLIC IKUR INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2012-04-19 | — | — | US | disclosed |
| US-7915410-B2 | Acyclic IKur inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-03-29 | — | — | US | disclosed |
| US-20070082909-A1 | Acyclic Ikur inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2007-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070082909-A1 | Acyclic Ikur inhibitors | KCNH2, KCNJ2, KCNH3 | TACR1 382/4885TSHR 566/4885GABBR2 1126/4885 |
| US-20120094983-A1 | ACYCLIC IKUR INHIBITORS | KCNH2, KCNJ2, KCNH3 | TACR1 382/4885TSHR 566/4885GABBR2 1126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.